Oligosaccharide System Suitability Mixture C
USP/1478232 - United States Pharmacopeia (USP) Reference Standard
Synonym: N-linked oligosaccharides from human α 1 acid-glycoprotein
Product Type: Chemical
| API family | oligosaccharide sst mixture |
| application(s) | USP Biologics pharmaceutical (small molecule) |
| form | solid |
| format | mixture |
| grade | pharmaceutical primary standard |
| manufacturer/tradename | USP |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Oligosaccharide System Suitability Mixture C USP reference standard suitable for use in specified USP compendial tests and assays. Also used to prepare AB-labeled standard solutions for liquid chromatographic separation. Additionally, used to separate Bi-, tri-, and tetra-antennary N-linked oligosaccharides with variable sialylation. |
| General description: | Oligosaccharide System Suitability Mixture C contains a series of saccharide fragments to test the suitability and reproducibility of chromatographic methods. It is used in the analysis of carbohydrate-based therapeutics and vaccines. The USP biologics carbohydrates category includes a variety of carbohydrate-based substances that are essential in the development and manufacturing of therapeutic products. These carbohydrates play crucial roles in biological processes and are often utilized as excipients, stabilizers, or active ingredients in pharmaceuticals. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of carbohydrate therapeutics throughout their lifecycle. The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics. |
| Other Notes: | Sales restrictions may apply. |
| Other Notes: | This product is part of the USP Biologics program. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |